The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
Dominique P. Germain(Assistance Publique – Hôpitaux de Paris), Marco Spada(University of Turin), Ilkka Kantola(Turku University Hospital), João Paulo Oliveira(Universidade do Porto), Albina Nowak(University of Zurich), Miguel Viana‐Baptista, Bruno Falissard(Inserm), Christoph Wanner(Universitätsklinikum Würzburg), В. В. Фомин(Sechenov University), Max J. Hilz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mehdi Namdar(Vrije Universiteit Brussel), Ana Jovanović(Manchester Academic Health Science Centre), Aleš Linhart(Charles University), Renzo Mignani(Ospedale Infermi di Rimini), Maurizio Pieroni(Ospedale San Donato), Perry Elliott(St Bartholomew's Hospital)
Cited by 233
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k